EGFR and non-small cell lung carcinoma: However, elevated lactate secretion and glycolysis were found in long-term TKI treatment of NSCLC cells and in prostate cancer cells [29–31], raising the possibility that glucose metabolic re-wiring may contribute to the development of acquired resistance of NSCLC to EGFR TKIs.